UK - £1 million new funding for world’s first end of Life Care Research Institute

Citation

(2009), "UK - £1 million new funding for world’s first end of Life Care Research Institute", International Journal of Health Care Quality Assurance, Vol. 22 No. 1. https://doi.org/10.1108/ijhcqa.2009.06222aab.011

UK - £1 million new funding for world’s first end of Life Care Research Institute

Article Type: News and views From: International Journal of Health Care Quality Assurance, Volume 22, Issue 1

Keywords: Healthcare research, Palliative healthcare, Quality improvements

Care Services Minister Ivan Lewis has announced a £1 millon grant to help build the world’s first purpose-built institute for research into end of life care.

The Cicely Saunders Institute for Palliative Care will enable leading researchers to work alongside each other in a purpose built building for and deliver palliative care solutions to patients, as well as providing education, patient information and support.

This follows on from the recently launched End of Life Care Strategy, backed with £286 million of Government funding. The grant is part of the Government’s ongoing commitment to provide high quality care for all adults approaching the end of their life.

Cicely Saunders International is working in partnership with King’s College London to build the Institute. The new building will bring together leading academics, healthcare professionals, community organisations, patients and carers.

The Department of Health grant will help meet the costs of constructing and fitting the Institute with teaching space for researchers and students as well as public spaces for patients and healthcare professionals.

The new institute will also provide the capacity to:

• •

  Increase the numbers of doctors and nurses trained at Kings College in end of life care best practice.

• •

  Provide facilities for research to discover better ways to care for patients at home, support caregivers and prevent and control symptoms.

• •

  Enable research to continue to examine support and treatments for conditions such as MS, end-stage renal disease, heart failure, chronic obstructive pulmonary disease (COPD) and cancer.

For more information: www.dh.gov.uk